Harvard Bioscience financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$64.75M $67.43M $76.18M $83.41M $88.05M $85.77M $108.18M $108.86M $111.17M $105.17M $108.66M $108.66M $104.52M $77.41M $120.77M $116.18M $102.10M $118.90M $113.34M $112.25M $0.00M
GM % Gross Margin %
49.01% 49.35% 50.00% 48.25% 48.16% 48.78% 47.96% 46.11% 47.08% 45.35% 45.41% 44.84% 46.32% 50.60% 55.46% 55.57% 56.85% 56.90% 54.96% 59.15% 0.00%
OM Operating Margin
13.41% 12.20% 11.41% 11.43% 11.68% 10.18% 9.98% 8.30% 7.95% 5.45% 6.29% -0.85% -1.09% -0.82% 3.96% 1.78% 0.22% 1.74% -4.58% 2.22% 0.00%
EPS Earnings Per Share
$0.19 $0.31 $0.36 $0.28 $0.22 $0.02 $0.27 $0.13 $0.15 $0.12 $0.20 $0.18 $0.16 $0.25 $0.12 $0.14 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
30.35m 30.46m 30.54m 30.81m 30.74m 29.47m 28.29m 28.5m 28.82m 31.01m 32.42m 33.94m 34.37m 34.88m 37.29m 38.07m 38.38m 38.98m 40.81m 42.69m 43.4m
OCF Operating Cash Flow
$11.44M $5.20M $8.36M $12.06M $9.20M $16.51M $12.29M $6.65M $8.06M $4.06M $4.35M $0.71M $5.38M $1.06M $2.88M $8.05M $9.33M $1.26M $1.15M $14.03M $0.00M
FCF Free Cash Flow
$8.43M $4.10M $5.98M $10.61M $7.89M $15.13M $11.45M $5.14M $6.29M $2.44M $2.35M $-2.26M $3.94M $0.17M $1.36M $6.83M $8.18M $0.07M $-0.44M $12.60M $0.00M
FCFS Free Cash Flow Per Share
$0.28 $0.13 $0.20 $0.35 $0.26 $0.51 $0.40 $0.18 $0.22 $0.08 $0.07 $-0.07 $0.12 $0.00 $0.05 $0.18 $0.21 $-0.00 $-0.01 $0.28 $0.00